LB-P2D
N/A
Report date: 2023/10/26 17:44:09
Base Information
Drug NameLB-P2D
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLISCure Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesThe Scripps Research Institute IncLISCure Biosciences Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A